COMPANY · NIPC 507336488

ACTELION PHARMACEUTICALS PORTUGAL, LDA

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €32,839,724.23 across 383 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameACTELION PHARMACEUTICALS PORTUGAL, LDA
NIPC507336488

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2019. The table below gives the same values.2012: €2,125,673.6320122013: €4,177,658.1220132014: €2,195,907.1120142015: €5,085,412.4220152016: €5,868,127.6220162017: €5,459,588.1920172018: €4,914,935.1420182019: €3,012,4222019€5,868,127.62
Contracted value by year
YearContractsContract value
201214€2,125,673.63
201331€4,177,658.12
201436€2,195,907.11
201562€5,085,412.42
201661€5,868,127.62
2017107€5,459,588.19
201860€4,914,935.14
201912€3,012,422
Contracted value by place of performance
NameContractsContract value
Lisboa107€11,429,217.73
Coimbra39€6,777,089.36
Porto4€2,963,778
Funchal14€2,235,919.83
Almada53€1,761,932.04
Portalegre48€1,640,253.10
Vila Nova de Gaia43€1,636,439.60
Elvas49€1,461,441.90
Faro15€872,986.20
Angra do Heroismo6€544,554.20
Largest contracts
SubjectYearContract value
P259-2018-178 Aquisição Medicamentos para Instituições do SNS2019€1,823,580
Bosentano 125 mg comp2015€1,442,042
Aquisição de Bosentano 125mg cap/comp2013€1,152,573.01
AQUISIÇÃO DE MEDICAMENTOS NO ÂMBITO DO DESPACHO 1571-B/2016-CENTRALIZAÇÃO 2018 - AGREGAÇÃO CIRCULAR INFORMATIVA CONJUNTA No8-2016 ACSS/INFARMED/SPMS - AD-AC-2017-1212018€1,105,200
procedimento n.o 040101842018 - compras centralizadas - SPMS - ref.a AD-AC-2017-1212018€946,788

Who they competed with

In 26 contracts with a list of competitors, the company took part and was awarded 14 (54%).

Companies with the most procedures in common
CompanyProcedures in common
Bayer Portugal SA2
Sanofi - Produtos Farmacêuticos, Lda2
SANDOZ FARMACEUTICA LDA2
Generis2
Accord Healthcare2
PROSPA LABORATÓRIOS FARMACÊUTICOS SA1
GLAXO SMITHKLINE PROD FARMACEUTICOS1
Johnson1
lab. atral1
JANSSEN CILAG FARMACEUTICA, LDA1
Labesfal, SA1
MYLAN1
Astrazeneca1
DLA Farmacêutica SA1
Fresenius kabi1
Pharmakern1
TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA1
AUROBINDO PHARMA PORTUGAL, (UNIP.) LDA1
AbbVie, Lda1

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents47 companies and 49 links. The list below gives the same content as text.Bayer Portugal… (NIPC 500043256)Bayer Portugal…NIPC 500063524 (NIPC 500063524)NIPC 500063524PROSPA LABORAT… (NIPC 500130248)PROSPA LABORAT…Sanofi - Produ… (NIPC 500134960)Sanofi - Produ…GLAXO SMITHKLI… (NIPC 500139962)GLAXO SMITHKLI…Johnson (NIPC 500153370)Johnsonlab. atral (NIPC 500162085)lab. atralLabesfal, SA (NIPC 501169580)Labesfal, SAAstrazeneca (NIPC 502942240)AstrazenecaFresenius kabi (NIPC 504293753)Fresenius kabiNIPC 507336488 (NIPC 507336488)NIPC 507336488+36 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

37 more links

Investigations that mention it

No published investigation mentions this company by NIPC.